Childhood brain tumors: epidemiology, current management and future directions

IF Pollack, RI Jakacki - Nature Reviews Neurology, 2011 - nature.com
Brain tumors are the most common solid tumors in children. With the increasingly widespread
availability of MRI, the incidence of childhood brain tumors seemed to rise in the 1980s, …

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre …

…, S Goldman, IF Pollack, I Qaddoumi, RI Jakacki… - The lancet …, 2019 - thelancet.com
Background Paediatric low-grade glioma is the most common CNS tumour of childhood.
Although overall survival is good, disease often recurs. No single universally accepted …

Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report

IF Pollack, RI Jakacki, SM Blaney, ML Hancock… - Neuro …, 2007 - academic.oup.com
This study estimated the maximum tolerated dose (MTD) of imatinib with irradiation in children
with newly diagnosed brainstem gliomas, and those with recurrent malignant intracranial …

A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium …

A Banerjee, RI Jakacki, A Onar-Thomas, S Wu… - Neuro …, 2017 - academic.oup.com
Background. Activation of the mitogen-activated protein kinase pathway is important for
growth of pediatric low-grade gliomas (LGGs). The aim of this study was to determine the …

Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults

RL Larsen, RI Jakacki, VL Vetter, AT Meadows… - The American journal of …, 1992 - Elsevier
Transient electrocardiographic changes and arrhythmias are known to be acute manifestations
of cardiotoxcity secondary to cancer therapy with anthracyclines or cardiac irradiation. …

[HTML][HTML] Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study

RI Jakacki, PC Burger, T Zhou, EJ Holmes… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
Purpose We evaluated the feasibility of administering carboplatin as a radiosensitizer
during craniospinal radiation therapy (CSRT) to patients with high-risk medulloblastomas (MBs) …

[HTML][HTML] Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid …

IF Pollack, RI Jakacki, LH Butterfield… - Journal of Clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Diffuse brainstem gliomas (BSGs) and other high-grade gliomas (HGGs) of childhood
carry a dismal prognosis despite current treatments, and new therapies are needed. …

IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group

…, MK Rosenblum, EJ Holmes, T Zhou, RI Jakacki… - Child's nervous …, 2011 - Springer
Purpose Recent studies have demonstrated a high frequency of IDH mutations in adult “secondary”
malignant gliomas arising from preexisting lower grade lesions, often in young adults…

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of …

RI Jakacki, KJ Cohen, A Buxton, MD Krailo… - Neuro …, 2016 - academic.oup.com
Background The prognosis for children with malignant glioma is poor. This study was
designed to determine whether lomustine and temozolomide following radiotherapy and …

Long‐term efficacy and toxicity of bevacizumab‐based therapy in children with recurrent low‐grade gliomas

EI Hwang, RI Jakacki, MJ Fisher… - Pediatric blood & …, 2013 - Wiley Online Library
Background Because definitive resection or radiotherapy for pediatric low‐grade gliomas (LGGs)
may be associated with severe and permanent adverse effects, medical management …